AphaseItrial of the aurora kinase inhibitor, ENMD-2076,in patients with relapsed or refractory acute myeloid leukemia or chronic myelomonocytic leukemia
Yee, Karen W. L., Chen, Hsiao-Wei T., Hedley, David W., Chow, Sue, Brandwein, Joseph, Schuh, Andre C., Schimmer, Aaron D., Gupta, Vikas, Sanfelice, Deborah, Johnson, Tara, Le, Lisa W., Arnott, Jamie,Volume:
34
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-016-0375-2
Date:
October, 2016
File:
PDF, 552 KB
english, 2016